Kelly Hares

981 total citations
24 papers, 739 citations indexed

About

Kelly Hares is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Kelly Hares has authored 24 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Cell Biology. Recurrent topics in Kelly Hares's work include Multiple Sclerosis Research Studies (6 papers), Genetic Neurodegenerative Diseases (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Kelly Hares is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Genetic Neurodegenerative Diseases (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Kelly Hares collaborates with scholars based in United Kingdom. Kelly Hares's co-authors include Alastair Wilkins, Neil Scolding, Kevin Kemp, Elizabeth Mallam, Mark Ginty, Claire M Rice, Juliana Redondo, Kate J. Heesom, Elizabeth Gray and Richard Ibitoye and has published in prestigious journals such as Nature Communications, PLoS ONE and Annals of Neurology.

In The Last Decade

Kelly Hares

24 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Hares United Kingdom 15 319 251 195 152 133 24 739
Ana Sofia Correia Portugal 14 575 1.8× 218 0.9× 249 1.3× 164 1.1× 110 0.8× 29 989
Anne DeChant United States 8 292 0.9× 242 1.0× 123 0.6× 206 1.4× 75 0.6× 10 779
Sara Morando Italy 12 315 1.0× 436 1.7× 104 0.5× 161 1.1× 131 1.0× 16 1.0k
И. И. Салафутдинов Russia 17 284 0.9× 248 1.0× 202 1.0× 83 0.5× 86 0.6× 60 684
Lingxiao Deng United States 19 312 1.0× 161 0.6× 357 1.8× 148 1.0× 325 2.4× 42 939
Giuseppe Busca Italy 12 219 0.7× 166 0.7× 165 0.8× 125 0.8× 50 0.4× 27 739
Berit Powers United States 9 350 1.1× 136 0.5× 172 0.9× 119 0.8× 106 0.8× 14 636
David Trisler United States 15 379 1.2× 107 0.4× 319 1.6× 266 1.8× 108 0.8× 28 885
Francisco Javier Rodríguez-Jiménez Spain 14 268 0.8× 143 0.6× 182 0.9× 183 1.2× 156 1.2× 20 605

Countries citing papers authored by Kelly Hares

Since Specialization
Citations

This map shows the geographic impact of Kelly Hares's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Hares with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Hares more than expected).

Fields of papers citing papers by Kelly Hares

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Hares. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Hares. The network helps show where Kelly Hares may publish in the future.

Co-authorship network of co-authors of Kelly Hares

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Hares. A scholar is included among the top collaborators of Kelly Hares based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Hares. Kelly Hares is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kemp, Kevin, Kelly Hares, Juliana Redondo, et al.. (2022). An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia. Nature Communications. 13(1). 4655–4655. 2 indexed citations
2.
Hares, Kelly, Kevin Kemp, Samantha Loveless, et al.. (2021). KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis. Journal of Neurology. 268(6). 2175–2184. 7 indexed citations
3.
Redondo, Juliana, Kelly Hares, Stephen Bailey, et al.. (2021). Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection. Multiple Sclerosis Journal. 28(8). 1179–1188. 4 indexed citations
4.
Haynes, Harry R., Kelly Hares, Juliana Redondo, et al.. (2018). Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays. Journal of Clinical Pathology. 71(8). 695–701. 13 indexed citations
5.
Kemp, Kevin, Kelly Hares, Juliana Redondo, et al.. (2018). Bone marrow transplantation stimulates neural repair in Friedreich's ataxia mice. Annals of Neurology. 83(4). 779–793. 11 indexed citations
6.
Hares, Kelly, J. Scott Miners, Claire M Rice, et al.. (2017). Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer’s Disease. Journal of Alzheimer s Disease. 60(4). 1511–1524. 32 indexed citations
7.
Hares, Kelly & Alastair Wilkins. (2017). Axonal Transport Proteins as Biomarkers of Neurodegeneration?. Biomarkers in Medicine. 11(8). 589–591. 3 indexed citations
8.
Kemp, Kevin, Juliana Redondo, Kelly Hares, et al.. (2016). Oxidative injury in multiple sclerosis cerebellar grey matter. Brain Research. 1642. 452–460. 22 indexed citations
9.
Haynes, Harry R., Paul White, Kelly Hares, et al.. (2016). The transcription factor PPARα is overexpressed and is associated with a favourable prognosis in IDH‐wildtype primary glioblastoma. Histopathology. 70(7). 1030–1043. 20 indexed citations
10.
Kemp, Kevin, Nadia L. Cerminara, Kelly Hares, et al.. (2016). Cytokine therapy‐mediated neuroprotection in a Friedreich's ataxia mouse model. Annals of Neurology. 81(2). 212–226. 23 indexed citations
11.
Redondo, Juliana, Kelly Hares, Alastair Wilkins, Neil Scolding, & Kevin Kemp. (2015). Reductions in kinesin expression are associated with nitric oxide‐induced axonal damage. Journal of Neuroscience Research. 93(6). 882–892. 23 indexed citations
12.
Redondo, Juliana, Kevin Kemp, Kelly Hares, et al.. (2014). Purkinje Cell Pathology and Loss in Multiple Sclerosis Cerebellum. Brain Pathology. 25(6). 692–700. 39 indexed citations
13.
Gray, Elizabeth, Kevin Kemp, Kelly Hares, et al.. (2014). Increased microglial catalase activity in multiple sclerosis grey matter. Brain Research. 1559. 55–64. 21 indexed citations
14.
Gray, Elizabeth, Claire M Rice, Kelly Hares, et al.. (2013). Reductions in neuronal peroxisomes in multiple sclerosis grey matter. Multiple Sclerosis Journal. 20(6). 651–659. 38 indexed citations
15.
Gray, Elizabeth, Claire M Rice, Helen Nightingale, et al.. (2012). Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis. Multiple Sclerosis Journal. 19(2). 153–161. 24 indexed citations
16.
Nightingale, Helen, Kevin Kemp, Elizabeth Gray, et al.. (2011). Changes in Expression of the Antioxidant Enzyme SOD3 Occur Upon Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells In Vitro. Stem Cells and Development. 21(11). 2026–2035. 31 indexed citations
17.
18.
Hares, Kelly, Kevin Kemp, Elizabeth Gray, Neil Scolding, & Alastair Wilkins. (2011). Neurofilament dot blot assays: Novel means of assessing axon viability in culture. Journal of Neuroscience Methods. 198(2). 195–203. 6 indexed citations
19.
Kemp, Kevin, Kelly Hares, Elizabeth Mallam, et al.. (2009). Mesenchymal stem cell‐secreted superoxide dismutase promotes cerebellar neuronal survival. Journal of Neurochemistry. 114(6). 1569–1580. 98 indexed citations
20.
Wilkins, Alastair, Kevin Kemp, Mark Ginty, et al.. (2009). Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Research. 3(1). 63–70. 225 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026